Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home

Completed

• Conditions: Anti Infective; Pediatric Population

• Registration Number: NCT04009785
• Lead Sponsor: Centre Hospitalier Universitaire de Nīmes

Brief Summary

Nowadays, resistance to anti-infectives has become a global public health problem and its increased prevalence threatens human health.

To date, few studies have focused on drug compliance in the paediatric population and it varies according to the pathology This drug adherence in the paediatric population is directly linked to outpatient care by the parents or the child's immediate family. In addition, there are no studies on adherence to antibiotics prescribed at the end of hospitalization in the paediatric population.

In this context, it seems urgent to seek an intervention capable of leading to responsible and appropriate use of antibiotics in order to improve efficiency in the drug management of acute paediatric infections.

This pilot study would characterize pediatric patients and determine the compliance rate in this population.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-06
• Primary Completion: 2018-05-04
• Study Completion: 2018-06-10
• Status Verified: 2019-06
• Study First Submitted: 2019-07-01
• Study First Submitted QC: 2019-07-03
• Study First Posted: 2019-07-05
• Last Update Submitted: 2019-08-05
• Last Update Posted: 2019-08-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• The patient is under 16 years of age (< 16 years of age).
• The patient is admitted to a full hospitalization in one of the 2 paediatric units of the University Hospital of Nîmes.
• The patient is discharged with a prescription for anti-infectives to be taken at home, for a maximum of 30 days.
• The patient and the holder of parental authority are available for a follow-up of 1 month after discharge from hospital.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of patients observing anti-infectives	2018

Secondary Outcome Measures

Name	Time	Method
Rehospitalization rates / emergency visits related to worsening infection	2018

Trial Locations

Locations (1)

Chu Nimes; 🇫🇷 Nîmes, France